Unverified50% confidenceFactExact time
The U.S. FDA has established a dedicated Digital Health Center of Excellence (DHCoE) to conduct pre-market review of AI/ML software as a medical device (SaMD).
1
Sources
50%
Confidence
Long-term
Relevance
9/19/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedUnder the major global regulatory frameworks, medical AI products are classified as Software as a Medical Device (SaMD); the U.S. FDA requires clearance through the 510(k) or PMA process, China's NMPA requires completion of Class III medical device registration, and the EU regulates them through the MDR.75% similarUnverifiedThe U.S. FDA classifies digital mental health tools into two categories: 'Software as a Medical Device' (SaMD) and 'General Wellness Software,' with the former requiring rigorous clinical validation and the latter being virtually unregulated.73% similarUnverifiedAs of 2024, the FDA has approved more than 800 AI/ML medical devices, with nearly all approvals positioning them as assistive diagnostic tools rather than independent decision-making systems.65% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/933941API
curl https://kongchang.com/api/v1/knowledge/claims/933941MCP
get_claim(id=933941)